HDFC Pharma And Healthcare Fund
NAV : ₹ 17.065 as of 17 December, 2025
Overview
₹ 2,010.77 Cr
Fund size
₹ 100
Min SIP
₹ 100
Lumpsum
14 September 2023
Launch date
Growth
Fund plan
Regular
Scheme type
Return Calculator
₹ 5,000
Over the past
Total Investment of ₹60,000
Monthly SIP of ₹5,000 would have become ₹61,554 in 1 year with a gain of ₹1,554 (+2.53%)
Disclaimer: Past performance is not an indicator of future returns
Top Holdings
Sun Pharmaceutical Industries Ltd. | 11.34% |
Divi's Laboratories Ltd. | 8.34% |
Lupin Ltd. | 6.40% |
Glenmark Pharmaceuticals Ltd. | 6.09% |
Max Healthcare Institute Ltd. | 6.07% |
Equity Holding(s) Distribution
Other Scheme Info
Expense Ratio
Inclusive of GST
2.1%
Stamp Duty
0.005%
Exit Load
Exit load of 1%, if redeemed within 30 days.
0
View Scheme Document
Peer Analysis
View more
Compare Funds
Compare with other funds
HDFC Pharma And Healthcare Fund Managers
List of HDFC Mutual Fund's top performing schemes
26.29% | |
25.81% | |
21.70% | |
21.36% | |
21.22% | |
20.62% | |
19.50% | |
18.42% | |
18.37% | |
16.75% |
Fund House
HDFC Mutual Fund
Total AUM: 939181.92Cr
HDFC Mutual Fund, managed by HDFC Asset Management Company Limited, was founded in 1999 through a collaboration between HDFC Limited and abrdn Investment Management Limited. Positioned as one of the largest mutual fund houses in India, it currently manages assets worth Rs. 5.56 lakh crore as of December 2023. The fund house transitioned to a publicly listed entity in August 2018.
Learn more about HDFC Mutual Fund
Kotak Securities Limited: AMFI-registered Mutual Fund Distributor
FAQ for HDFC Pharma And Healthcare Fund
Start SIP with just Rs.100
Start SIP with just Rs.100